All six of the most critical ICGs that were examined, including CD274, CTLA4, HAVCR2, IDO1, PDCD1, and PDCD1LG2, exhibited a significant positive correlation with the risk scores in glioma samples (Figure 6A). The gene discussed is PDCD1LG2; the disease is central nervous system cancer.